Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin After Reperfusion in Extended-Window Endovascular Thrombectomy
NCT06339411Phase 2Not yet recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Modality
- Native Peptides
01
Overview
A Phase 2 trial of cerebrolysin in ischemic stroke, sponsored by Chang Gung Memorial Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06339411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06339411.